Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FGTW (Clottafact) in paediatric severe congenital fibrinogen deficiency
2013-000261-36Phase 2Completed
- Sponsor
- LFB Group
- Start
- Apr 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Fibrinogen human in congenital afibrinogenemia and congenital hypofibrinogenemia, sponsored by LFB Group. Primary endpoint: Investigator overall assessment of haemostatic efficacy. Started Apr 2014; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
congenital afibrinogenemiacongenital hypofibrinogenemia
Beyond the preview
Go deeper on 2013-000261-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000261-36.